U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 698

1.
Time Course of Reversal of Fentanyl‐Induced Respiratory Depression in Healthy Subjects by Intramuscular Nalmefene and Intramuscular and Intranasal Naloxone
Alessandra Cipriano, Glen Apseloff, Ram P. Kapil, Ellie He, Manjunath Shet, Stephen C. Harris
J Clin Pharmacol. 2025 Feb; 65(2): 206–216. Published online 2024 Sep 30. doi: 10.1002/jcph.6132
PMCID:
PMC11771590
ArticlePDF–540K
2.
The Rise of Fentanyl: Molecular Aspects and Forensic Investigations
Cecilia Barletta, Virginia Di Natale, Massimiliano Esposito, Mario Chisari, Giuseppe Cocimano, Lucio Di Mauro, Monica Salerno, Francesco Sessa
Int J Mol Sci. 2025 Jan; 26(2): 444. Published online 2025 Jan 7. doi: 10.3390/ijms26020444
PMCID:
PMC11765396
ArticlePDF–696K
3.
Research and clinical implications of emerging evidence regarding patterns of postoperative opioid-induced respiratory depression
Toby N Weingarten, Atousa Deljou, Juraj Sprung
Biomol Biomed. 2025 Feb 1; 25(2): 327–337. Published online 2025 Feb 1. doi: 10.17305/bb.2024.11123
PMCID:
PMC11734825
ArticlePDF–2.1M
4.
Modeling Insights into Potential Mechanisms of Opioid-Induced Respiratory Depression within Medullary and Pontine Networks
Wendy L. Olsen, John A. Hayes, Dale Shuman, Kendall F. Morris, Donald C. Bolser
Version 1. bioRxiv. Preprint. 2024 Dec 21. doi: 10.1101/2024.12.19.628766
PMCID:
PMC11702709
ArticlePDF–9.8M
5.
Tandospirone prevents anesthetic-induced respiratory depression through 5-HT1A receptor activation in rats
Meng-ran Song, Ming-zhi Huang, Wei-jie Tao, Zheng Yong, Rui-bin Su
Sci Rep. 2025; 15: 653. Published online 2025 Jan 3. doi: 10.1038/s41598-024-84440-x
PMCID:
PMC11698729
ArticlePDF–2.4M
6.
Real-World Safety of Esketamine Nasal Spray: A Comprehensive Analysis of Esketamine and Respiratory Depression
Craig Chepke, Richard Shelton, Gerard Sanacora, Teodora Doherty, Palina Tsytsik, Nancy Parker
Int J Neuropsychopharmacol. 2024 Dec; 27(12): pyae058. Published online 2024 Nov 29. doi: 10.1093/ijnp/pyae058
PMCID:
PMC11635826
ArticlePDF–573K
7.
ENA-001 Reverses Xylazine/Fentanyl Combination-Induced Respiratory Depression in Rats: A Qualitative Pilot Study
Thomas L Miller, Jeanette Mathews, George C Dungan, Joseph V Pergolizzi, Robert B Raffa
Cureus. 2024 Nov; 16(11): e74826. Published online 2024 Nov 30. doi: 10.7759/cureus.74826
PMCID:
PMC11608063
ArticlePDF–539K
8.
Management of Acute and Chronic Hypercapnic Respiratory Failure in Severe Obesity-Hypoventilation Syndrome: A Case Study of Multi-Modal Therapy and Long-Term Weight Loss
Miori Kitamura, Hajime Kasai, Jiro Terada, Ken Koshikawa, Kenichi Suzuki, Takuji Suzuki
Am J Case Rep. 2024; 25: e945448. Published online 2024 Nov 14. doi: 10.12659/AJCR.945448
PMCID:
PMC11591300
ArticlePDF–2.0M
9.
Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
Muhammad Waqar Ashraf, Satu Poikola, Mikko Neuvonen, Johanna I. Kiiski, Vesa K. Kontinen, Klaus T. Olkkola, Janne T. Backman, Mikko Niemi, Teijo I. Saari
Clin Pharmacokinet. 2024; 63(11): 1547–1560. Published online 2024 Oct 23. doi: 10.1007/s40262-024-01433-9
PMCID:
PMC11573879
ArticlePDF–1.4M
10.
Cardiorespiratory and muscle oxygenation responses to voluntary hypoventilation at low lung volume in upper body repeated sprints
Cristóvão H. Rosa, Cristina P. Monteiro, Cláudia Barata, Mário C. Espada, Maria João Valamatos, André Bento, Ricardo J. Minhalma, Joana Filipa Reis
Eur J Appl Physiol. 2024; 124(12): 3741–3754. Published online 2024 Aug 13. doi: 10.1007/s00421-024-05569-1
PMCID:
PMC11568980
ArticlePDF–1.0M
11.
Effects of Slow Breathing Exercises on Cardiac Autonomic Functions in Anxiety Disorder—A Randomised Control Trial
Natarajan Kavitha, Pravati Pal, Gopal Krushna Pal, Balaji Bharadwaj, Nivedita Nanda
Ann Neurosci. 2024 Sep 23 : 09727531241266094. doi: 10.1177/09727531241266094 [Epub ahead of print]
PMCID:
PMC11559497
ArticlePDF–486K
12.
Comparative efficacy of ciprofol and propofol in reducing respiratory depression during ERCP anesthesia: a randomized controlled trial
Juanhong Wang, Rui Wang, Xiaofang Ma, Wenjing Zhu, Baoping Zhang, Yuhu Ma, Yatao Liu
BMC Anesthesiol. 2024; 24: 404. Published online 2024 Nov 8. doi: 10.1186/s12871-024-02791-4
PMCID:
PMC11546404
ArticlePDF–1.5M
13.
PRODIGY score predicts respiratory depression in the post-anesthesia care unit: A post-hoc analysis
Anuradha Kanaparthi, Frances Chung, Peter R Lichtenthal, Juraj Sprung, Toby N Weingarten
Biomol Biomed. 2024 Dec 1; 24(6): 1662–1668. Published online 2024 Dec 1. doi: 10.17305/bb.2024.10585
PMCID:
PMC11496848
ArticlePDF–876K
14.
Mechanistic pharmacokinetic–pharmacodynamic modeling and simulations of naloxone auto‐injector 10 mg reversal of opioid‐induced respiratory depression
Tae Eun Yang, Francesca Del Bene, Silvia Maria Lavezzi, Laura Iavarone, Jianping Zhang, Joseph Kim, Breanne Gjurich, Catherine Kessler
CPT Pharmacometrics Syst Pharmacol. 2024 Oct; 13(10): 1722–1733. Published online 2024 Sep 16. doi: 10.1002/psp4.13215
PMCID:
PMC11494827
ArticlePDF–2.5M
15.
The link between fear of disease progression and health promotion behaviors in patients with obstructive sleep apnea hypoventilation syndrome (OSAHS): the mediating role of social support
Fan Zhang, Chunguang Liang, Chunyan Zhang, Kaiyan Xu, Qing Chen, Huameng Xu, Huiying Zhang
BMC Psychol. 2024; 12: 557. Published online 2024 Oct 15. doi: 10.1186/s40359-024-02059-z
PMCID:
PMC11481426
ArticlePDF–1.4M
16.
Incidence of respiratory depression between ciprofol and propofol after anesthesia: A systematic review and meta-analysis
Jinfang Zeng, Qian Cao, Aonan Hong, Zhen Gu, Jinjin Jian, Xiao Liang
Medicine (Baltimore) 2024 Oct 11; 103(41): e40037. Published online 2024 Oct 11. doi: 10.1097/MD.0000000000040037
PMCID:
PMC11479517
ArticlePDF–2.1M
17.
Perry Disease: Current Outlook and Advances in Drug Discovery Approach to Symptomatic Treatment
Zbigniew Gajda, Magdalena Hawrylak, Jadwiga Handzlik, Kamil J. Kuder
Int J Mol Sci. 2024 Oct; 25(19): 10652. Published online 2024 Oct 3. doi: 10.3390/ijms251910652
PMCID:
PMC11476970
ArticlePDF–21M
18.
Hypoventilation training including maximal end-expiratory breath holding improves the ability to repeat high-intensity efforts in elite judo athletes
X. Woorons, C. Faucher, S. P. Dufour, F. Brocherie, P. Robach, P. Connes, J. V. Brugniaux, S. Verges, A. F. Gaston, G. Millet, O. Dupuy, A. Pichon
Front Physiol. 2024; 15: 1441696. Published online 2024 Sep 27. doi: 10.3389/fphys.2024.1441696
PMCID:
PMC11467534
ArticlePDF–1.6M
19.
Management of Obesity Hypoventilation Syndrome in Extreme Obesity: A Case Study
Yuya Miyoshi, Tetsuya Yumoto, Yoshinori Kosaki, Takashi Hongo, Kohei Tsukahara, Atsunori Nakao, Hiromichi Naito
Am J Case Rep. 2024; 25: e945112. Published online 2024 Oct 2. doi: 10.12659/AJCR.945112
PMCID:
PMC11460406
ArticlePDF–830K
20.
Identification of a histone deacetylase inhibitor as a therapeutic candidate for congenital central hypoventilation syndrome
Chiara Africano, Tiziana Bachetti, Paolo Uva, Gabriel Pitollat, Genny Del Zotto, Francesca Giacopelli, Giada Recchi, Nicolas Lenfant, Amélia Madani, Nathan Beckouche, Muriel Thoby-Brisson, Isabella Ceccherini
Mol Ther Nucleic Acids. 2024 Dec 10; 35(4): 102319. Published online 2024 Sep 3. doi: 10.1016/j.omtn.2024.102319
PMCID:
PMC11426119
ArticlePDF–4.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center